| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.486 | 4.983 | 4.895 | 7.897 |
| Total Income - EUR | - | - | - | - | - | - | 1.486 | 4.983 | 4.895 | 7.897 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.173 | 1.164 | 2.631 | 1.388 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 313 | 3.819 | 2.265 | 6.509 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 268 | 3.669 | 1.946 | 5.520 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alineuromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 353 | 4.000 | 6.250 | 8.789 |
| Inventories | - | - | - | - | - | - | 283 | 963 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 217 | 1.524 | 3.552 |
| Cash | - | - | - | - | - | - | 70 | 2.820 | 4.726 | 5.237 |
| Shareholders Funds | - | - | - | - | - | - | 308 | 3.979 | 5.912 | 8.777 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 45 | 22 | 337 | 12 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alineuromed S.r.l.